Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03062384 · ClinicalTrials.gov registry record · NA
AT-001 for Long-term Preservation of Brain Health in Aging
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 95
- Enrollment target
NCT03062384: Completed NA study, sponsored by University of Kentucky.
NCT03062384 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 95 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03062384, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if the use of a yeast-selenium supplement (AT-001) is safe in elderly subjects who do not have dementia, and further, to see if the supplement improves tests that are related to brain health.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT AT-001
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
What the finished NCT03062384 record still lists
NCT03062384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03062384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03062384 about?
NCT03062384 is a clinical study titled "AT-001 for Long-term Preservation of Brain Health in Aging". The purpose of this study is to evaluate if the use of a yeast-selenium supplement (AT-001) is safe in elderly subjects who do not have dementia, and further, to see if the supplement improves tests that are related to brain health.
What is the current status of trial NCT03062384?
This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2016-05. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03062384?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), AT-001 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03062384?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03062384's enrollment target sits among peer trials
95 931st of 2000 higher than 1,066 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia